Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients

Sadeleştirilmiş öğe sayfası
dc.contributor.authorHasimi, Adnan
dc.contributor.authorDogan, Oezlem
dc.contributor.authorSerdar, Ceyhan Ceran
dc.contributor.authorSerdar, Muhittin A.
dc.date.accessioned2025-10-16T15:16:01Z
dc.date.issued2023
dc.identifier.doi10.11613/BM.2023.010701
dc.identifier.otherWOS:000925840500008
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6599
dc.publisherCROATIAN SOC MEDICAL BIOCHEMISTRY \& LABORATORY MEDICINE
dc.sourceBIOCHEMIA MEDICA
dc.subjectSARS\\-CoV\\-2
dc.subjectasymmetric dimethylarginine \\(ADMA\\)
dc.subjectN\\-monomethyl\\-1\\-arginine \\(L\\-NMMA\\)
dc.subjectprognosis
dc.titleAssociation of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS